Real-time enrollment status for this diabetic retinopathy clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 7:18 AM UTC
| NCT Number | NCT06770933 |
| Recruiting Status | Recruiting |
| Condition | Diabetic Retinopathy |
| Phase | Clinical Trial |
| Target Enrollment | 100 participants |
| Active Locations | 8 sites in the US |
| Sponsor | Vantage Biosciences Ltd |
| Last Updated on CT.gov | June 18, 2025 (Jun 18, 2025) |
As of March 2, 2026: Clinical trial NCT06770933 is currently recruiting participants. This clinical trial study for diabetic retinopathy is actively seeking new participants at 8 locations across the United States. The study is sponsored by Vantage Biosciences Ltd. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06770933 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06770933 was last updated Jun 18, 2025 (June 18, 2025). HelloStudys verifies this status automatically.